STEPHANIE SLASKI: Open Payments
NPI 1790182434 · DEVON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 81 payments from 16 companies in 2025. Trend: 2023 $2,916 · 2024 $3,204 · 2025 $1,418
Food & beverage: $1,308Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $407 |
| Janssen Biotech, Inc. | 15 | $315 |
| GENZYME CORPORATION | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| UCB, Inc. | 3 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $50 |
| Organon LLC | 5 | $47 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $43 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, COSENTYX, Bimzelx, Otezla, ILUMYA.
Industry payments across PA — which companies pay providers there.
